Brenntag to showcase latest pharma innovation at CPHI India 2025
A key highlight will be Brenntag’s qualified amino acids portfolio
A key highlight will be Brenntag’s qualified amino acids portfolio
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
The proposed transaction will be effected as a share swap
These certifications reflect the company's continuous commitment to maintaining international standards of environmental sustainability as well as occupational health and safety
The company will soon be launching a new portfolio of products in this segment
Topline results from the Phase 2 VISTA trial show that PIPE-307 did not meet its primary or secondary efficacy endpoints
The partnership will enable rapid and reliable product delivery
Subscribe To Our Newsletter & Stay Updated